PL2992094T3 - Kompozycje i sposoby leczenia cukrzycy typu 1 - Google Patents
Kompozycje i sposoby leczenia cukrzycy typu 1Info
- Publication number
- PL2992094T3 PL2992094T3 PL14791797T PL14791797T PL2992094T3 PL 2992094 T3 PL2992094 T3 PL 2992094T3 PL 14791797 T PL14791797 T PL 14791797T PL 14791797 T PL14791797 T PL 14791797T PL 2992094 T3 PL2992094 T3 PL 2992094T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- compositions
- treatment
- methods
- type
- Prior art date
Links
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361818671P | 2013-05-02 | 2013-05-02 | |
| PCT/US2014/036394 WO2014179586A1 (en) | 2013-05-02 | 2014-05-01 | Compositions and methods for treatment of type 1 diabetes |
| EP14791797.5A EP2992094B1 (en) | 2013-05-02 | 2014-05-01 | Compositions and methods for treatment of type 1 diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2992094T3 true PL2992094T3 (pl) | 2019-03-29 |
Family
ID=51843952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14791797T PL2992094T3 (pl) | 2013-05-02 | 2014-05-01 | Kompozycje i sposoby leczenia cukrzycy typu 1 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20160068585A1 (pl) |
| EP (1) | EP2992094B1 (pl) |
| JP (2) | JP2016518844A (pl) |
| CN (1) | CN105408478A (pl) |
| CY (1) | CY1120861T1 (pl) |
| DK (1) | DK2992094T3 (pl) |
| ES (1) | ES2687189T3 (pl) |
| HR (1) | HRP20181445T1 (pl) |
| HU (1) | HUE040421T2 (pl) |
| LT (1) | LT2992094T (pl) |
| PL (1) | PL2992094T3 (pl) |
| PT (1) | PT2992094T (pl) |
| SI (1) | SI2992094T1 (pl) |
| WO (1) | WO2014179586A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6895148B1 (ja) * | 2020-03-31 | 2021-06-30 | クラシエホールディングス株式会社 | 冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定用マーカー、冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定方法、及び冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定するための判定用キット |
| JP2023542341A (ja) * | 2020-09-21 | 2023-10-06 | エスアールアイ インターナショナル | 標的化された抗原送達システム及びその使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002045735A2 (en) * | 2000-12-08 | 2002-06-13 | University Technologies International, Inc. | Nrp-derived peptides useful for treating insulin-dependent diabetes mellitus |
| US20120035105A1 (en) * | 2009-01-09 | 2012-02-09 | Sdg, Inc. | Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments |
| US20180092991A1 (en) * | 2009-06-05 | 2018-04-05 | Bayhill Therapeutics, Inc. | Compositions and methods for treatment of insulin-dependent diabetes mellitus |
| WO2012015903A1 (en) * | 2010-07-27 | 2012-02-02 | Bayhill Therapeutics, Inc. | Treatment of type i diabetes mellitus (t1dm) in young newly diagnosed patients |
-
2014
- 2014-05-01 JP JP2016512043A patent/JP2016518844A/ja not_active Withdrawn
- 2014-05-01 EP EP14791797.5A patent/EP2992094B1/en not_active Not-in-force
- 2014-05-01 HU HUE14791797A patent/HUE040421T2/hu unknown
- 2014-05-01 US US14/888,639 patent/US20160068585A1/en not_active Abandoned
- 2014-05-01 CN CN201480038111.XA patent/CN105408478A/zh active Pending
- 2014-05-01 ES ES14791797.5T patent/ES2687189T3/es active Active
- 2014-05-01 PT PT14791797T patent/PT2992094T/pt unknown
- 2014-05-01 SI SI201430885T patent/SI2992094T1/sl unknown
- 2014-05-01 DK DK14791797.5T patent/DK2992094T3/en active
- 2014-05-01 HR HRP20181445TT patent/HRP20181445T1/hr unknown
- 2014-05-01 LT LTEP14791797.5T patent/LT2992094T/lt unknown
- 2014-05-01 WO PCT/US2014/036394 patent/WO2014179586A1/en not_active Ceased
- 2014-05-01 PL PL14791797T patent/PL2992094T3/pl unknown
-
2018
- 2018-09-06 CY CY181100931T patent/CY1120861T1/el unknown
- 2018-11-21 US US16/197,578 patent/US20190315827A1/en not_active Abandoned
-
2019
- 2019-02-04 JP JP2019017697A patent/JP2019080574A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2992094A4 (en) | 2016-12-28 |
| EP2992094A1 (en) | 2016-03-09 |
| DK2992094T3 (en) | 2018-09-03 |
| PT2992094T (pt) | 2018-10-18 |
| WO2014179586A1 (en) | 2014-11-06 |
| US20190315827A1 (en) | 2019-10-17 |
| HUE040421T2 (hu) | 2019-03-28 |
| HRP20181445T1 (hr) | 2018-11-16 |
| EP2992094B1 (en) | 2018-06-20 |
| JP2016518844A (ja) | 2016-06-30 |
| CN105408478A (zh) | 2016-03-16 |
| CY1120861T1 (el) | 2019-12-11 |
| LT2992094T (lt) | 2018-11-12 |
| SI2992094T1 (sl) | 2018-12-31 |
| ES2687189T3 (es) | 2018-10-24 |
| US20160068585A1 (en) | 2016-03-10 |
| JP2019080574A (ja) | 2019-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| IL246252A0 (en) | Diaminopyrimidyl derivative compounds, their compositions and methods of treatment | |
| IL243758B (en) | Methods and preparations for the treatment of brain diseases | |
| ZA201506487B (en) | Therapeutic compounds and compositions | |
| SG11201601471SA (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| IL239921A0 (en) | Preparations containing solutions in solid state and their use for the treatment of pain | |
| SG11201509782TA (en) | Compositions and methods for the treatment of diabetes and pre-diabetes | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| PT3021839T (pt) | Composições para o tratamento da fibrose | |
| SG11201510300RA (en) | Compositions and methods for treating skin | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| ZA201509360B (en) | Compositions and methods for treatment of stroke | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| HUE040421T2 (hu) | Készítmények és eljárások 1-es típusú cukorbetegség kezelésére | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| ZA201408053B (en) | Compositions and methods for the treatment of metabolic syndrome | |
| IL245675A0 (en) | Therapeutic regimen and method for treating type 2 diabetes | |
| GB201310349D0 (en) | Composition and method of use thereof | |
| GB201301928D0 (en) | Composition and method of use thereof | |
| GB201303721D0 (en) | Compositions for treatment of sleep disorders |